| Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper-and hypomethylated targets VF Chekhun, NY Lukyanova, O Kovalchuk, VP Tryndyak, IP Pogribny Molecular cancer therapeutics 6 (3), 1089-1098, 2007 | 150 | 2007 |
| Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin VF Chekhun, NY Lukyanova, АP Burlaka, NA Bezdenezhnykh, ... International journal of oncology 43 (5), 1481-1486, 2013 | 99 | 2013 |
| Improved Synthesis of N-Benzylaminoferrocene-Based Prodrugs and Evaluation of Their Toxicity and Antileukemic Activity S Daum, VF Chekhun, IN Todor, NY Lukianova, YV Shvets, L Sellner, ... Journal of medicinal chemistry 58 (4), 2015-2024, 2015 | 80 | 2015 |
| Molecular profile and cell cycle in MCF-7 cells resistant to cisplatin and doxorubicin NY Lukyanova, NV Rusetskya, NA Tregubova, VF Chekhun Experimental oncology, 2009 | 79 | 2009 |
| The lipid content of cisplatin-and doxorubicin-resistant MCF-7 human breast cancer cells IN Todor, NY Lukianova, VF Chekhun Experimental oncology, 2012 | 77 | 2012 |
| Роль генов р53 и bcl-2 в апоптозе и лекарственной резистентности опухолей НЮ Лукьянова, ГИ Кулик, ВФ Чехун Вопр. онкол 46 (2), 121-128, 2000 | 71 | 2000 |
| Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype S Chekhun, N Bezdenezhnykh, J Shvets, N Lukianova Experimental oncology, 174-179, 2013 | 63 | 2013 |
| Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells SV Chekhun, NY Lukyanova, YV Shvets, AP Burlaka, LG Buchynska Experimental oncology, 179-183, 2014 | 38 | 2014 |
| Gold nanoparticles synthesis and biological activity estimation in vitro and in vivo LS Rieznichenko, SM Dybkova, TG Gruzina, ZR Ulberg, IN Todor, ... Experimental Oncology, 2012 | 35 | 2012 |
| Vascular endothelial growth factor exression in uterine cervical cancer: correlation with clinicopathologic characteristics and survival IV Goncharuk, LI Vorobjova, NY Lukyanova, VF Chekhun Experimental oncology, 2009 | 33 | 2009 |
| Clinical significance of hormonal receptor status of malignant ovarian tumors IG Tkalia, LI Vorobyova, VS Svintsitsky, SV Nespryadko, IV Goncharuk, ... Experimental oncology, 125-133, 2014 | 32 | 2014 |
| The role of expression of the components of proteome in the formation of molecular profile of human ovarian carcinoma A2780 cells sensitive and resistant to cisplatin. VF Chekhun, NY Lukyanova, OV Urchenko, GI Kulik Experimental oncology 27 (3), 191-195, 2005 | 31 | 2005 |
| Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients VF Chekhun, VE Zhylchuk, NY Lukyanova, AL Vorontsova, YI Kudryavets Experimental oncology, 2009 | 29 | 2009 |
| New hybrid composites for photodynamic therapy: synthesis, characterization and biological study N Kutsevol, A Naumenko, Y Harahuts, V Chumachenko, I Shton, ... Applied Nanoscience 9, 881-888, 2019 | 24 | 2019 |
| Association of cd44⁺ cd24⁻/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer VF Chekhun, NY Lukianova, SV Chekhun, NO Bezdieniezhnykh, ... Experimental Oncology, 2017 | 23 | 2017 |
| Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis OD Ryabtseva, NY Lukianova, YA Shmurakov, LZ Polishchuk, ... Experimental oncology, 211-218, 2013 | 22 | 2013 |
| Molecular profile and cell cycle in MCF-7 and MCF‑7/Dox cells exposed to conventional and liposomal forms of doxorubicin NV Rusetskaya, NY Lukyanova, VF Chekhun Experimental oncology, 2009 | 22 | 2009 |
| Relation between cell-to-cell adhesion and angiogenesis and clinico-morphological prognostic factors in patients with gastric cancer VM Bazas, NY Lukyanova, DV Demash, KO Galakhin, DV Myasoedov Experimental oncology, 2008 | 22 | 2008 |
| Prevention of myelosuppression by combined treatment with enterosorbent and granulocyte colony-stimulating factor OO Shevchuk, KA Posokhova, IN Todor, NY Lukianova, VG Nikolaev, ... Experimental oncology, 135-138, 2015 | 21 | 2015 |
| Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs TM Yalovenko, IM Todor, NY Lukianova, VF Chekhun Experimental oncology, 2016 | 19 | 2016 |
